Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.37 USD
Change Today +0.12 / 3.69%
Volume 958.7K
CRIS On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 5:20 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - curis inc (CRIS)

NameBoard RelationshipsTitleAge
Ali Fattaey Ph.D.8 RelationshipsChief Executive Officer, President and Director49
Michael P. Gray No RelationshipsChief Financial Officer, Principal Accounting Officer, Chief Business Officer and Secretary43
Daniel R. Passeri MSc., J.D.8 RelationshipsVice Chairman and Strategic Advisor53
Jaye Viner M.D., MPHNo RelationshipsChief Medical Officer and Executive Vice President57

Board Members - curis inc (CRIS)

NameBoard RelationshipsPrimary CompanyAge
James R. McNab Jr., MBA20 RelationshipsPalmetto Pharmaceuticals, Inc.70
Ali Fattaey Ph.D.8 RelationshipsCuris, Inc.49
Daniel R. Passeri MSc., J.D.8 RelationshipsCuris, Inc.53
Martyn D. Greenacre MBA52 RelationshipsZynaxis, Inc.72
James R. Tobin 34 RelationshipsBSC International Corporation69

Executive Committees* - curis inc (CRIS)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeMartyn D. Greenacre MBA 52 Relationships2 Executives
Compensation CommitteeJames R. Tobin 34 Relationships3 Executives
Nominating CommitteeKenneth I. Kaitin Ph.D. 26 Relationships2 Executives
Corporate Governance CommitteeKenneth I. Kaitin Ph.D. 26 Relationships2 Executives
Advisory BoardKenneth J. Pienta M.D. 8 Relationships1 Executives
View CRIS Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRIS:US $3.37 USD +0.12

CRIS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ArQule Inc $1.81 USD +0.01
CTI BioPharma Corp $1.94 USD +0.04
Cytokinetics Inc $6.37 USD +0.11
Exelixis Inc $3.15 USD +0.02
Navidea Biopharmaceuticals Inc $1.25 USD -0.04
View Industry Companies
 

Industry Analysis

CRIS

Industry Average

Valuation CRIS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 34.3x
Price/Book 4.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 28.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CURIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.